Sidley Represents Nurix Therapeutics in Multi-Year Strategic Collaboration With Seagen to Advance New Class of Cancer Therapeutics

Advising firms

The announcement does not name individual lawyers.

Want co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.

Stated terms

Stated value

USD 60m (US$60 million)

What the figure measures

Total transaction value

Client

Nurix Therapeutics, Inc.Joint venture party

Counterparties

Seagen Inc. (Joint venture party)